Thermo Fisher Scientific Inc (TMO)

TMO (NYSE:Health Services) EQUITY
$172.33
pos +0.50
+0.29%
Today's Range: 171.28 - 172.44 | TMO Avg Daily Volume: 1,614,800
Last Update: 05/24/17 - 4:02 PM EDT
Volume: 827,903
YTD Performance: 21.78%
Open: $171.81
Previous Close: $171.83
52 Week Range: $139.07 - $173.64
Oustanding Shares: 391,219,918
Market Cap: 67,328,947,888
6-Month Chart
TheStreet Ratings Grade for TMO
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 12 12
Moderate Buy 0 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 1
Mean Rec. 1.15 1.18 1.43 1.43
Latest Dividend: 0.15
Latest Dividend Yield: 0.35%
Dividend Ex-Date: 06/13/17
Price Earnings Ratio: 31.35
Price Earnings Comparisons:
TMO Sector Avg. S&P 500
31.35 31.40 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
8.25% 15.45% 48.46%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.70 0.40 0.12
Net Income 2.30 0.60 0.16
EPS 3.50 0.50 0.13
Earnings for TMO:
EBITDA 4.40B
Revenue 18.27B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $2.26 $2.24 $9.22 $10.22
Number of Analysts 11 9 13 11
High Estimate $2.28 $2.28 $9.25 $10.81
Low Estimate $2.22 $2.21 $9.20 $10.03
Prior Year $2.03 $2.03 $8.27 $9.22
Growth Rate (Year over Year) 11.33% 10.56% 11.46% 10.89%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Anders Keitz

 | Oct 7, 2016 | 2:15 PM EDT
The highly elusive Cleveland Research is putting the screws to Fitbit.
RMPIA
By

Anders Keitz

 | Oct 3, 2016 | 12:30 PM EDT
One firm's channel checks hit some of the market's biggest giants -- meaning investors should keep an eye on the Midwest.
RMPIA
By

Anders Keitz

 | Sep 26, 2016 | 2:26 PM EDT
A handful of financial firms are establishing their roots in the Midwest, but that doesn't mean the boys in the Big Apple don't use the resources...
RMPIA
By

Guy Ortmann

 | Sep 26, 2016 | 12:55 PM EDT
Thermo Fisher is looking bullish, while Blue Buffalo goes the other way.
RMPIA

bullishThermo Fisher added to Analyst Focus List at JP Morgan

Sep 22, 2016 | 6:56 AM EDT
TMO was placed on the Analyst Focus list, JP Morgan said. $180 price target. FEI acquisition should add $0.30 a share to annual earnings in the first year. Overweight rating.
RMPIA
By

Anders Keitz

 | Sep 19, 2016 | 2:49 PM EDT
Smaller, independent equity research firms are starting to cause bigger waves in the marketplace, but is the information really that valuable?
RMPIA
By

David Katz

 | Sep 14, 2016 | 8:00 AM EDT
The recent pullback will be a pause that refreshes, positioning the company for its next leg up.
RMPIA
By

Anders Keitz

 | Jul 29, 2016 | 4:20 PM EDT
Zimmer Biomet is on track to return to growth, which could signal more mergers and acquisitions within the industry.
RMPIA
By

Jim Cramer

 | May 27, 2016 | 10:43 AM EDT
Thermo Fisher plans to buy microscope maker FEI for about $4.2 billion and Jim Cramer says FEI shareholders should take the money and run.
RMPIA
By

Anders Keitz

 | May 27, 2016 | 8:55 AM EDT

Also, Thermo Fisher annouces an acquisition as takeover talks boost Valeant shares. 

Sally Beauty's CEO put his money to work buying 10,000 shares on the new low today (@ $17....
HD began last Tuesday's session with a huge earnings inspired upside gap. In the early goi...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.